SHS News

Rietheim-Weilheim / Tübingen, 8 July 2025 Healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The investment aims to expand Ackermann’s core business and, through partnerships and acquisitions of additional companies, build a leading, globally positioned MedTech group. Ackermann Instrumente GmbH, headquartered near Tuttlingen, is a leading manufacturer of high-quality surgical […]

Tuebingen / 13.03.2025 Selfapy GmbH, a digital health pioneer in the field of mental health, has been acquired by MEDICE Health Family, the European market leader in ADHD therapy. As part of the transaction, the investors SHS Capital, Think.Health Ventures, IBB Ventures, and HTGF sold their shares. Selfapy’s CE-certified medical products provide flexible and easily […]

Tuebingen / 13.02.2025 Healthcare specialist SHS Capital has taken an important step in its long-term succession planning and is securing further growth. Lukas Maucher, who joined SHS in 2022 from one of the Big Four auditing firms and has served as CFO since then, will take on the role of Managing Partner, overseeing finance and […]

Hamburg / Tübingen / Dresden, 15 January 2025 The Healthcare Specialists GENUI and SHS Capital are jointly investing in ROTOP, a leading European manufacturer and CDMO for radiopharmaceuticals. ROTOP Pharmaka GmbH, founded in 2000 and based in Dresden-Rossendorf, is a leading supplier of radiopharmaceutical products. Radioactive pharmaceuticals are increasingly being used, both for diagnostic applications […]

Tübingen / 26 November 2024 SHS Capital acquires a majority stake in the therapy and rehabilitation home care provider MTR. The aim of the investment is to further grow the core business and support the nationwide expansion that has already been initiated. Medizintechnik Rostock GmbH is a home care provider for therapy devices, founded in […]

Tuebingen / 07.10.2024 SHS Capital is pleased to announce a significant investment alongside its limited partners in one of its portfolio companies, Develco. SHS Capital has been a committed investor since 2020 and is pleased to have offered its LPs the opportunity to co-invest in Develco. Develco is a specialty pharma company focused on the […]

The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size The new fund will invest in European growing healthcare companies and allocates […]

SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors The company’s core product is the ESSERT MicroFactory, a modular production platform for the automation of low-volume, high-mix […]

CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders This investment is the third transaction […]

Spiegelberg GmbH & Co. KG is one of the leading suppliers in the field of manufacturing devices and consumables for intracranial pressure measurement and has been able to grow strongly in recent years  Luciole Medical AG, which specialises in cerebral monitoring and measurement of oxygen saturation in the brain, is expanding its product range with […]

SHS partners with the founders of MESI, a fast-growing Slovenia-based diagnostic company growing revenues >50% p.a. in the last 5 years MESI’s cutting-edge technology digitalizes medical assessment, resulting in workflow optimisation, cost saving and improved patient outcomes The investment aims to further accelerate MESI’s growth and global market presence, and help to transform healthcare with […]

SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]